Sign in
4

Changes in Ownership

HAEMONETICS CORP Filed Acc 0000313143-14-000122

CFO & EVP Business Development returned 1,310 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

LINDOP CHRISTOPHER J · CFO & EVP Business Development

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-10-27 Returned to the company : show line 1 in the form −628 $36.22 $22,746 38,273 D
2014-10-28 Returned to the company : show line 2 in the form −682 $36.22 $24,702 37,591 D
Loading xslF345X03/edgardoc.xml…